ArticleJournal of experimental & clinical cancer research : CR2024
Correction: Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.
Jiaojiao Hao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.